Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin and Gemcitabine for Regionally Advanced or Metastatic Urothelial Cancer

NCT00237575 is registered in ClinicalTrials.gov with University of Kentucky as lead sponsor.

NCT NCT00237575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin and Gemcitabine for Regionally Advanced or Metastatic Urothelial Cancer
Lead sponsor
University of Kentucky
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2005
Completion date
March 31, 2006
Enrollment
100
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer